Journal: Journal of autoimmunity

Article Title: InÊvivo effector functions of high-affinity mouse IgG receptor Fc?RI in disease and therapy models.

PMID/MRN: 27745779

Publication Date: 2016-Oct-10

Abstract:

Two activating mouse IgG receptors (Fc?Rs) have the ability to bind monomeric IgG, the high-affinity mouse Fc?RI and Fc?RIV. Despite high circulating levels of IgG, reports using Fc?RI -/- or Fc?RIV -/- mice or Fc?RIV-blocking antibodies implicate these receptors in IgG-induced disease severity or therapeutic Ab efficacy. From these studies, however, one cannot conclude on the effector capabilities of a given receptor, because different activating Fc?Rs possess redundant properties inÊvivo, and cooperation between Fc?Rs may occur, or priming phenomena. To help resolve these uncertainties, we used mice expressing only Fc?RI to determine its intrinsic properties inÊvivo. Fc?RI only mice were sensitive to IgG-induced autoimmune thrombocytopenia and anti-CD20 and anti-tumour immunotherapy, but resistant to IgG-induced autoimmune arthritis, anaphylaxis and airway inflammation. Our results show that the inÊvivo roles of Fc?RI are more restricted than initially reported using Fc?RI -/- mice, but confirm effector capabilities for this high-affinity IgG receptor inÊvivo. Copyright © 2016 Elsevier Ltd. All rights reserved.